Medical Murray’s Post

“The well-trodden path in medtech doesn’t always have to be the default. It’s possible to put collaboration over competition and develop partnership-driven models where incentives truly are aligned.” Our CEO David Hochman was recently featured in Scott Nelson’s article in MD+DI on the value of taking the less-trodden path. Learn more about Orchestra BioMed’s unique approach for success: #innovation #medtech #PatientFirst

The importance of product market fit? Had a great chat with with one of our advisors, who was sharing about their experience working as a Design Engineer in a start-up based in the US. As the chief Design Engineer, he was responsible for research and development of a new device that would be targeted at surgeons performing vascular surgery, specifically open surgical procedures. By all accounts, they would be seen as successful having fundraised over USD 26 million over three rounds. In a short period of time they were forced to cease operations . Some of the lessons learnt: - In any development process, especially in Medtech, prioritising the must-haves and good to haves is important. Time is limited. - End users are important both in the feedback and development process. Understanding what clinicians as well as healthcare professionals are saying, not only in terms of the technology itself, but on a macro level, where and how the therapeutic area are moving. - There are different avenues to funding; VC, Angel. Ultimately it needs to be a fit for both sides. As a start-up it is important to ask why company x? What is the value beyond funding? Access to a network? Work out what is the best path for your side. - Having the right founding team is critical. Those with the vision, rhetoric WHY. Those will help carry out the vision, the HOW. - As Viktor Kyosev highlights velocity is key. Speed of innovation is critical. What is relevant today in a short period of time won’t be so relevant in the near future, as was the case with this start-up. The field has already moved to minimally invasive. - At the same time though, knowing that healthcare is unique and complex. Knowing when and how to slow down, to focus on areas such as regulatory, interoperability when it comes to digital, clinician and industry insights, both shared in detail by Dr. Derrick Khor Dr Terence Tan, MBBS, MSc, GDFM, GDOM. #medtech #startups #innovation

Latest DON Therapeutics News The medtech industry, a fusion of physical and digital innovations, is revolutionizing patient care and boosting the efficiency of healthcare systems. Among these innovations, medical devices stand out as critical components. These devices encompass a wide range of products, including instruments, machines, implants, and tools designed to diagnose, treat, prevent, or mitigate health conditions. The onset of the global pandemic marked a significant turning point for the medtech industry. Initially, like many sectors, medtech faced considerable challenges due to disrupted supply chains and constrained budgets, which hindered production and innovation. However, the pandemic ultimately served as a catalyst for rapid growth within this space, a trend that is expected to persist. The pandemic underscored the medtech industry's potential to enhance patient outcomes and streamline healthcare processes. This recognition has opened up vast opportunities across various healthcare sectors. As a result, the medical device industry is not only poised for continuous expansion but is also attracting substantial interest from investors eager to capitalize on its high growth potential. More about DON Therapeutics: https://lnkd.in/eKs-9g9e We are always looking for new healthcare opportunities. Submit your opportunity: https://lnkd.in/dJfhwVvv #funding #biotechnology #medtech #startups #investors

Sterling Industries signs MoU with ventureLAB to boost MedTech innovation in Vaughan, advancing medical device development and supporting entrepreneurs through cutting-edge resources. Sterling Industries ventureLAB #MedTech #medicaldevice #Vaughan #hardware #semiconductor #MoU #medicalinnovation #Canada #medicalelectronics #latestelectronicsnews

Is milestone-based pricing right for your medical device development? In just 90 seconds, discover: ▶ Why milestone-based pricing is critical for high-risk products such as implantable devices ▶ How fixed-cost pricing ensures transparency and accountability at every stage ▶ Why clients trust our structured, milestone-driven development process ▶ How this model drives better project management and timely delivery 🎥 Watch the video and let us know what you think! #MedicalDeviceInnovation #MilestonePricing #FixedCostPricing #Startup #Cashflow

Shout out to our friend, Randy Horton, for digging into the state of SaMD approvals in the U.S.! Randy and Orthogonal partnered with Brian Binkowski to build a database to gain a clearer picture of the state of SaMD approvals in the U.S. See the article below for more information about the rapidly growing SaMD segment! #SaMD | MedTech Startup | Lifeblood | Capital + Talent | #DigitalHealth | #MedTech

Navigating the dynamic world of #medtech startups demands more than innovation; it requires strategic wisdom rooted in a lot of experience. In my latest article for MD+DI, I've curated some invaluable tips from a few phenomenal entrepreneurs on how to best position an early-stage #medicaldevices company for success. Here's a sneak peek: ➡️ Will Martin, CEO of IRRAS AB, emphasizes robust quality management as the linchpin for future M&A opportunities. ➡️ David Kuraguntla, CEO of Alio, shares the power of aligning the 4Ps to foster growth - Patient, Physician, Product, and Provider. ➡️ Tim Blair, CEO of ICHOR Vascular Inc., advocates for securing funding that aligns with your vision and attracts sophisticated investors. ➡️ Steve Dimmer, former CEO of CurvaFix, Inc., advises addressing major challenges early on to stand out in a crowded market and streamline regulatory processes. ➡️ Ohad Arazi, CEO of Clarius Mobile Health, encourages entrepreneurs to not be afraid of charting their own regulatory course by demonstrating the clinical value of their product. For a deep dive into these strategies and more, check out the full article here: https://lnkd.in/g3mziq3C . As always, thanks to Omar Ford and Amanda Pedersen for their publishing support! 🙌🏼

For companies developing SaMD for the US market, this is an interesting read. I was surprised that the majority of companies have only one FDA clearance and the fairly equal distribution between US and non-US companies.

🦄 According to Venturelab, #Swiss #MedTech company Artiria Medical has just secured $6 Million in a Series A2 funding round. ⚕ Artiria Medical is revolutionising neurovascular healthcare with cutting-edge minimally invasive medical technologies. 🚷 Their first product, an innovative FDA-cleared wire with a micro-articulated seeking head, dramatically improves navigation through cerebral vessels to treat strokes. Current interventional devices lack control, leading to complications, increased costs and longer surgical procedures. 🏥 Artiria Medical 's innovation improves precision, reduces risk and improves patient outcomes. 🦄 Founded by COO Marc Boers and CEO Guillaume Petit-Pierre. 💬 "We are thrilled to announce that Artiria Medical has successfully secured $6M in a Series A2 funding round, and an additional $0.6M FIT Tech Growth loan!!! Following promising first in-human results and FDA clearance, this major milestone enables further clinical deployment of our pioneering real-time deflectable guidewire technology, which already shows significant traction from neurointerventional physicians." Artiria Medical LinkedIn Press release 💸 This financing round was led by 4FOX Ventures and joined by the Wyss Center for Bio and Neuroengineering, Verve Ventures, ZKB and Nest Sammelstiftung. 🔻 Read Venturelab's full article, by Rita Longobardi here: https://lnkd.in/g4eipANx 🔦 We at the Swiss Chamber of Commerce in The Netherlands (SCCN) wish Artiria Medical  nothing but 💪 for 2024! . . . . Brought to you by The Digital Socialitez - Official digital marketing and social media management partner of Swiss Chamber of Commerce in The Netherlands (SCCN) . . . #SwissChamberofCommerceInTheNetherlands #SCCN #BusinessExpansion #EuropeanMarket #MarketAccess #StrategicGrowth #BusinessOpportunities #BusinessGrowth #Entrepreneurs #Startups #Investors #Europeannews #euronews #Europeaninvestment  #Europeaninvestments #Europeanfunding #TechUK #TechGermany #TechFrance #TechNetherlands #TechSweden #StartupNetherlands #StartupSweden #StartupNorway

In the latest episode of Medtech Talk, host Geoff Pardo speaks with Shifamed founder and CEO Amr Salahieh about how to successfully pursue the path of entrepreneurship. As the founder of several companies, including Sadra Medical, Maya Medical, and Apama Medical, Salahieh shares his methods behind finding the right markets and taking care of your investors. He also talks about his thoughts on the biggest challenge. Listen to the conversation here: https://lnkd.in/eHkfRraJ